RESUMEN
The recent COVID-19 pandemic has resulted in increased hand hygiene and hand cleansing awareness. To prevent virus transmission, the Centers for Disease Control and Prevention recommends frequent hand washing with soap and water. Hand hygiene products are available in a variety of forms, and while each of these formulations may be effective against COVID-19, they may also alter skin barrier integrity and function. As health care workers and the general population focus on stringent hand hygiene, the American Contact Dermatitis Society anticipates an increase in both irritant contact and allergic contact hand dermatitis. Alcohol-based hand sanitizers with moisturizers have the least sensitizing and irritancy potential when compared to soaps and synthetic detergents. This article provides an overview of the most frequently used hand hygiene products and their associations with contact dermatitis as well as recommendations from the American Contact Dermatitis Society on how to treat and prevent further dermatitis.
Asunto(s)
Dermatitis por Contacto/prevención & control , Dermatitis Profesional/prevención & control , Dermatosis de la Mano/prevención & control , Higiene de las Manos/normas , Guías de Práctica Clínica como Asunto , Antiinfecciosos Locales/administración & dosificación , Antiinfecciosos Locales/efectos adversos , Betacoronavirus/patogenicidad , COVID-19 , Control de Enfermedades Transmisibles/métodos , Control de Enfermedades Transmisibles/normas , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/prevención & control , Infecciones por Coronavirus/transmisión , Infecciones por Coronavirus/virología , Dermatitis por Contacto/etiología , Dermatitis Profesional/etiología , Dermatosis de la Mano/inducido químicamente , Personal de Salud , Humanos , Irritantes/administración & dosificación , Irritantes/efectos adversos , Pandemias/prevención & control , Neumonía Viral/epidemiología , Neumonía Viral/prevención & control , Neumonía Viral/transmisión , Neumonía Viral/virología , SARS-CoV-2 , Jabones/efectos adversos , Sociedades Médicas/normas , Estados UnidosRESUMEN
OBJECTIVES: Systemic allergic reactions to nickel alloys in percutaneous atrial septal defect occlusion devices have a poorly defined natural history. We describe our experience of surgical removal of the offending device in a series of patients with nickel allergy and refractory symptoms. METHODS: Patients with atrial septal defect device explants for nickel allergy were reviewed. Administered questionnaires focused on symptoms, quality of life, and satisfaction along with the 36-Item Short Form Health Survey to measure physical and mental health postsurgery. RESULTS: Atrial septal defect devices were removed for nickel allergy in 58 patients during the past 10 years. The median age was 42 years (range, 24-71 years) and 95% were women. Explantation occurred at a median of 8 years (range, 6 months-18 years) after insertion. Symptoms included fatigue (82%), chest pain (78%), headache (73%), and palpitation (58%). Surveys were available for 45 patients: 58% rated their quality of life as poor and 69% were not at all satisfied with their device. Postexplant, all patients reported improvement in their symptoms, with 18 patients (42%) noting complete resolution. In 12 patients prospectively studied, the preoperative scores in physical and mental health domains were lower than the validation group, indicating significant disability. Similarly, there was marked improvement in each domain postremoval. CONCLUSIONS: Patients with nickel allergy and severe refractory symptoms after atrial septal defect device implantation experience profound resolution of symptoms and improved quality of life after removal. Nickel allergy should be considered before device insertion, and a low threshold should exist for surgical removal for refractory symptoms.
Asunto(s)
Cateterismo Cardíaco/efectos adversos , Cateterismo Cardíaco/instrumentación , Remoción de Dispositivos , Defectos del Tabique Interatrial/terapia , Hipersensibilidad/cirugía , Níquel/efectos adversos , Dispositivo Oclusor Septal/efectos adversos , Adulto , Anciano , Bases de Datos Factuales , Remoción de Dispositivos/efectos adversos , Femenino , Estado de Salud , Humanos , Hipersensibilidad/diagnóstico , Hipersensibilidad/etiología , Masculino , Salud Mental , Persona de Mediana Edad , Satisfacción del Paciente , Diseño de Prótesis , Calidad de Vida , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Factores de Tiempo , Resultado del Tratamiento , Adulto JovenAsunto(s)
Continuidad de la Atención al Paciente/organización & administración , Dermatología/organización & administración , Personas con Mala Vivienda/estadística & datos numéricos , Cooperación del Paciente/estadística & datos numéricos , Enfermedades de la Piel/terapia , Adulto , Continuidad de la Atención al Paciente/estadística & datos numéricos , Dermatología/estadística & datos numéricos , Registros Electrónicos de Salud/estadística & datos numéricos , Femenino , Humanos , Perdida de Seguimiento , Masculino , Persona de Mediana Edad , Derivación y Consulta/estadística & datos numéricos , Enfermedades de la Piel/diagnósticoRESUMEN
PURPOSE: To assess the effectiveness of lectures for continuing medical education (CME) in dermatology in a global health setting and to determine provider and patient demographics of physician assistants (PAs) practicing in rural Ghana. METHODS: Physician assistants from Ghana who attended dermatology lectures at the International Seminar for Physician Assistants in 2011 or 2014 were included in this study. Surveys were administered to participants to determine dermatology resource availability, commonly encountered skin diseases, and management practices. Quizzes were administered before and after CME dermatology lectures to assess short-term retention of lecture material. RESULTS: In all, 353 PAs participated in this study. Physician assistants reported seeing an average of 55 patients per day. The most commonly seen skin diseases were infections, with antifungals and antibiotics being the most commonly prescribed medications. Dermatology-related complaints represented 9.5% of total clinic visits. Among practicing PAs, 23.2% reported having internet access. A total of 332 PAs completed the quizzes, and a statistically significant increase in test scores was noted in postlecture quizzes. CONCLUSIONS: This study reinforces the importance of dermatology education for PAs practicing in rural areas of Ghana and lends insight to critical topics for dermatology curriculum development. In addition, the increase in test scores after CME sessions suggests that lectures are an effective tool for short-term retention of dermatology-related topics. Our study indicates that as the need for health workers increases globally and a paradigm shift away from the traditional physician model of care occurs, dermatology training of PAs is not only important but also achievable.
Asunto(s)
Dermatología/educación , Educación Continua/organización & administración , Asistentes Médicos/educación , Población Rural , Enfermedades de la Piel/epidemiología , Educación Continua/normas , Ghana/epidemiología , Humanos , Enfermedades de la Piel/diagnóstico , Enfermedades de la Piel/terapia , Factores SocioeconómicosRESUMEN
The Euphorbiaceae family (commonly known as "spurge") is a large, diverse, and widely distributed family of plants that encompass around 300 genera and more than 8000 species. Their attractiveness and hearty nature have made them popular for both indoor ornamentation and outdoor landscaping. Despite their ubiquity, the potential to cause irritant contact dermatitis (ICD) is often overlooked in favor of more notorious causes of phytodermatitis, namely, Toxicodendron species and nettles. We examined case reports spanning 40 years and discovered that spurge-induced ICD tends to befall children and middle-aged adults who unwittingly encounter the plant through play or horticulture, respectively. Clinical presentation is pleomorphic. Erythema, edema, burning, vesicles, and pruritus of acute onset and rapid resolution are frequently observed. We present a classic case of ICD in a 12-year-old girl after exposure to Euphorbia myrsinites and review the literature on phytodermatitis caused by members of the Euphorbiaceae family.
Asunto(s)
Dermatitis Alérgica por Contacto/diagnóstico , Dermatitis por Toxicodendron/diagnóstico , Euphorbia/efectos adversos , Niño , Dermatitis Alérgica por Contacto/etiología , Diagnóstico Diferencial , Euphorbiaceae , Femenino , HumanosRESUMEN
The American Contact Dermatitis Society recognizes the interest in the evaluation and management of metal hypersensitivity reactions. Given the paucity of robust evidence with which to guide our practices, we provide reasonable evidence and expert opinion-based guidelines for clinicians with regard to metal hypersensitivity reaction testing and patient management. Routine preoperative evaluation in individuals with no history of adverse cutaneous reactions to metals or history of previous implant-related adverse events is not necessary. Patients with a clear self-reported history of metal reactions should be evaluated by patch testing before device implant. Patch testing is only 1 element in the assessment of causation in those with postimplantation morbidity. Metal exposure from the implanted device can cause sensitization, but a positive metal test does not prove symptom causality. The decision to replace an implanted device must include an assessment of all clinical factors and a thorough risk-benefit analysis by the treating physician(s) and patient.
Asunto(s)
Dermatitis Alérgica por Contacto/diagnóstico , Metales , Pruebas del Parche , Prótesis e Implantes , Humanos , Sociedades MédicasRESUMEN
BACKGROUND: Nickel is the most common allergen found by patch testing; however, not all cases of nickel allergy are type 4 (delayed) allergies. Contact urticaria (CU) to nickel (immediate reaction) has been reported; however, few seem to evaluate it as per a recent published survey of American Contact Dermatitis Society members. OBJECTIVE: The aim of the study was to present a series of patients who had clinical histories suggestive of nickel allergy and yet were patch test negative but prick test positive to nickel, thus demonstrating CU. METHODS: We reviewed the charts of 11 patients who were patch test negative but prick test positive. RESULTS: All 11 patients demonstrated evidence of CU by prick testing (or closed chamber test in 1). None were patch test positive to nickel 2.5% or 5.0%. Four patients' histories mentioned reactions to various jewelry/earrings within minutes, whereas 2 histories mentioned reacting within a few hours. These histories are consistent with CU. Others (except 1 patient) recalled reacting to jewelry/earrings but did not recall a time frame. CONCLUSIONS: Our series suggests that CU to nickel may be far more common than anticipated and should be evaluated with prick testing when patients' history suggests nickel allergy and yet they are patch test negative.
Asunto(s)
Urticaria/diagnóstico , Adulto , Anciano , Femenino , Humanos , Pruebas Intradérmicas/métodos , Irritantes/efectos adversos , Masculino , Persona de Mediana Edad , Níquel/efectos adversos , Pruebas del Parche/métodos , Urticaria/inducido químicamenteAsunto(s)
Antiinflamatorios/efectos adversos , Dermatitis Alérgica por Contacto/etiología , Erupciones por Medicamentos/etiología , Triamcinolona/efectos adversos , Adulto , Dermatitis Alérgica por Contacto/patología , Eritema Multiforme/etiología , Eritema Multiforme/patología , Reacciones Falso Negativas , Femenino , Humanos , Pruebas del ParcheRESUMEN
IMPORTANCE: Microneedle therapy includes skin puncture with multiple micro-sized needles to promote skin rejuvenation or increase transdermal delivery of topical medications. In cosmetic practices, various cosmeceuticals are applied before microneedling to enhance the therapeutic effects. This results in intradermal tattooing of the topical product. Despite rapid increase in the use of microneedles in dermatology, there are few data about their safety. OBSERVATIONS: We describe 3 women, aged 40s to 60s, who developed open [corrected] facial granulomas following microneedle therapy for skin rejuvenation. Two patients had undergone microinjection of the same branded topical moisturizer (Vita C Serum; Sanítas Skincare) during microneedle therapy. Biopsy in all cases showed foreign body-type granulomas. Results of tissue cultures were negative. Chest radiography and serum angiotensin-converting enzyme findings were normal. The first 2 patients had a positive patch test reaction to Vita C Serum. Initial treatment with topical and oral corticosteroids was ineffective. Therapy with doxycycline hydrochloride and minocycline hydrochloride led to partial improvement in one case and resolution in another. CONCLUSIONS AND RELEVANCE: Application of topical products prior to microneedling can introduce immunogenic particles into the dermis and potentiate local or systemic hypersensitivity reactions. Because the microneedle therapy system is accessible for home use, health care providers need to be aware of its potential consequences.
Asunto(s)
Erupciones por Medicamentos/etiología , Dermatosis Facial/inducido químicamente , Granuloma de Cuerpo Extraño/inducido químicamente , Envejecimiento de la Piel , Adulto , Fármacos Dermatológicos/administración & dosificación , Fármacos Dermatológicos/efectos adversos , Doxiciclina/uso terapéutico , Erupciones por Medicamentos/patología , Dermatosis Facial/patología , Femenino , Estudios de Seguimiento , Granuloma de Cuerpo Extraño/patología , Humanos , Microinyecciones , Persona de Mediana Edad , Minociclina/uso terapéutico , Agujas , RejuvenecimientoRESUMEN
BACKGROUND: Chronic urticaria (CU) is a cutaneous disease that can be debilitating, difficult to treat, and sometimes life-threatening. Treatment with antihistamines is often ineffective. Immunosuppressants are second line therapy but can have significant side effects. Data is needed on effective therapies with safer profiles. OBJECTIVES: To determine the efficacy and side-effects of colchicine in patients with CU. METHODS: Patients were identified through retrospective chart reviews at the University of Utah from 2002-2007. We identified 36 patients with a diagnosis of chronic urticaria based on history, physical examination, and a skin biopsy. Length of treatment ranged from one month to 17 months. RESULTS: Subjective clinical responses to colchicine therapy reported as complete (n=15) or partial (n=5) were found in 56 percent of patients. The mean±SD duration of treatment was 7±6 months. Three patients (15%) who had resolution of urticaria stopped colchicine secondary to diarrhea and hematuria. Of the complete responders, nine individuals (60%) have remained symptom free and four individuals (27%) had recurrence after colchicine was stopped. LIMITATIONS: Short-term follow-up and retrospective study design. CONCLUSIONS: This retrospective study demonstrated that colchicine was an effective and well-tolerated treatment for patients unresponsive to antihistamines. The data supports the use of colchicine for CU patients and further controlled studies are warranted to better characterize the use of colchicine in patients with CU refractory to antihistamines.